SEQUANA MEDICAL NV (SEQUA.BR)
BE0974340722 - Common Stock
Taking everything into account, SEQUA scores 1 out of 10 in our fundamental rating. SEQUA was compared to 56 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SEQUA have multiple concerns. SEQUA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SEQUA has reported negative net income.
In the past year SEQUA has reported a negative cash flow from operations.
In the past 5 years SEQUA always reported negative net income.
SEQUA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SEQUA has a worse Return On Assets (-251.92%) than 98.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -251.92% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-200.39%
ROA(5y)-179.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SEQUA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SEQUA has more shares outstanding
Compared to 5 years ago, SEQUA has more shares outstanding
The debt/assets ratio for SEQUA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -34.11, we must say that SEQUA is in the distress zone and has some risk of bankruptcy.
SEQUA's Altman-Z score of -34.11 is on the low side compared to the rest of the industry. SEQUA is outperformed by 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -34.11 |
ROIC/WACCN/A
WACC7.2%
2.3 Liquidity
A Current Ratio of 0.41 indicates that SEQUA may have some problems paying its short term obligations.
With a Current ratio value of 0.41, SEQUA is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
A Quick Ratio of 0.29 indicates that SEQUA may have some problems paying its short term obligations.
SEQUA's Quick ratio of 0.29 is on the low side compared to the rest of the industry. SEQUA is outperformed by 96.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.41 | ||
| Quick Ratio | 0.29 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 24.73% over the past year.
SEQUA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.54%.
Measured over the past years, SEQUA shows a decrease in Revenue. The Revenue has been decreasing by -7.10% on average per year.
EPS 1Y (TTM)24.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.17%
Revenue 1Y (TTM)-48.54%
Revenue growth 3Y-9.58%
Revenue growth 5Y-7.1%
Sales Q2Q%-72.54%
3.2 Future
The Earnings Per Share is expected to grow by 22.91% on average over the next years. This is a very strong growth
Based on estimates for the next years, SEQUA will show a very strong growth in Revenue. The Revenue will grow by 159.77% on average per year.
EPS Next Y32.24%
EPS Next 2Y33.77%
EPS Next 3Y22.91%
EPS Next 5YN/A
Revenue Next Year-71.06%
Revenue Next 2Y59.13%
Revenue Next 3Y159.77%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SEQUA. In the last year negative earnings were reported.
Also next year SEQUA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SEQUA's earnings are expected to grow with 22.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.77%
EPS Next 3Y22.91%
5. Dividend
5.1 Amount
SEQUA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SEQUANA MEDICAL NV
EBR:SEQUA (1/6/2025, 7:00:00 PM)
3.56
+0.54 (+17.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners37.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap158.21M
Analysts83.64
Price Target4.73 (32.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.66%
PT rev (3m)-11.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)0.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 364.95 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0.01
BVpS-0.44
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -251.92% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-200.39%
ROA(5y)-179.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 100.03% | ||
| Cap/Sales | 151.95% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.41 | ||
| Quick Ratio | 0.29 | ||
| Altman-Z | -34.11 |
F-Score2
WACC7.2%
ROIC/WACCN/A
Cap/Depr(3y)134.82%
Cap/Depr(5y)117.19%
Cap/Sales(3y)87.02%
Cap/Sales(5y)61.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.17%
EPS Next Y32.24%
EPS Next 2Y33.77%
EPS Next 3Y22.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-48.54%
Revenue growth 3Y-9.58%
Revenue growth 5Y-7.1%
Sales Q2Q%-72.54%
Revenue Next Year-71.06%
Revenue Next 2Y59.13%
Revenue Next 3Y159.77%
Revenue Next 5YN/A
EBIT growth 1Y23.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.85%
EBIT Next 3Y14.39%
EBIT Next 5YN/A
FCF growth 1Y1.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.39%
OCF growth 3YN/A
OCF growth 5YN/A